It depends what you consider the market.
Kaken basically had 200,000 new patients in the first year, I think BOT will have more.
Not only that. Every BOT patient that renews the script , effectively doubles the patient numbers, since most Japanese on average buy 1 script only. Most americans buy 2.
So although market penetration might oly be 2% or whatever.... if they renew 4 scripts on average.... that is the exquivalent of 4x market penetration in income.
Based on what happened in Japan, it is entirely feasable that the sales in year 1 will be around the 1 billion mark.
Take the same year 1 sales Kaken had, adjust for USA being 3 x the size, and adjust for the fact that USA on average renew 2 scripts where as Japan do not renew. That gives you 900,000 USD in sales ~ or about 1.3 to 1.4 Billion in AUS sales.
The first quarter report will be the first indication of where on that scale we are.
- Forums
- ASX - By Stock
- Ann: Trading Halt
It depends what you consider the market.Kaken basically had...
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $725.6M |
Open | High | Low | Value | Volume |
39.5¢ | 41.0¢ | 39.5¢ | $2.436M | 6.081M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 185492 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 10290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 185492 | 0.400 |
7 | 505666 | 0.395 |
8 | 376217 | 0.390 |
7 | 205759 | 0.385 |
7 | 299581 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 10290 | 1 |
0.410 | 475742 | 16 |
0.415 | 388908 | 9 |
0.420 | 515887 | 14 |
0.425 | 210504 | 6 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |